Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C37H45F3N6O5 |
Molecular Weight | 710.7856 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC(OC)=C1CN2CC[C@H](N3CCN(CC3)C4=CC=C(N[C@H]5CCC(=O)NC5=O)C=C4F)C(F)(F)C2)C6=CN(C)C(=O)C(C)=C6C
InChI
InChIKey=GNRGNRCQXHMQQV-ZQAZVOLISA-N
InChI=1S/C37H45F3N6O5/c1-22-23(2)36(49)43(3)19-26(22)24-16-31(50-4)27(32(17-24)51-5)20-44-11-10-33(37(39,40)21-44)46-14-12-45(13-15-46)30-8-6-25(18-28(30)38)41-29-7-9-34(47)42-35(29)48/h6,8,16-19,29,33,41H,7,9-15,20-21H2,1-5H3,(H,42,47,48)/t29-,33-/m0/s1
Molecular Formula | C37H45F3N6O5 |
Molecular Weight | 710.7856 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:50:34 GMT 2023
by
admin
on
Sat Dec 16 18:50:34 GMT 2023
|
Record UNII |
AW8PEP3VZ3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
865121
Created by
admin on Sat Dec 16 18:50:34 GMT 2023 , Edited by admin on Sat Dec 16 18:50:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
AW8PEP3VZ3
Created by
admin on Sat Dec 16 18:50:34 GMT 2023 , Edited by admin on Sat Dec 16 18:50:34 GMT 2023
|
PRIMARY | |||
|
163203607
Created by
admin on Sat Dec 16 18:50:34 GMT 2023 , Edited by admin on Sat Dec 16 18:50:34 GMT 2023
|
PRIMARY | |||
|
2704617-96-7
Created by
admin on Sat Dec 16 18:50:34 GMT 2023 , Edited by admin on Sat Dec 16 18:50:34 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->DEGRADER |
PRECLINICAL
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
CFT8634 is a novel Bifunctional Degradation Activating Compound Degrader, also known as a BiDAC™ degrader, of bromodomain-containing protein 9 (BRD9). CFT8634 is comprised of
ligand binding moieties for BRD9 and the cereblon (CRBN) E3 ligase. CRBN facilitates E3 ligasecatalyzed ubiquitination of BRD9. Following polyubiquitination, BRD9 is then degraded by the cellular proteasome.
|